Shorts

0:52
How Remote Blood Pressure Monitoring Helps Manage Patients With CKD: Anitha Vijayan, MD
a year ago
by
Sabrina McCrear(+1 more)

0:47
The Hidden Cardiovascular Risks Across a Woman's Lifespan: Melvin Echols, MD
a year ago
by
Sabrina McCrear(+1 more)

1:46
Out-of-Network HOPDs Double Outpatient Surgery Costs for Patients, Insurers: Xiaoxi Zhao, PhD
a year ago
by
Brooke McCormick(+1 more)

0:37
Understanding Pediatric Eczema Severity and Body Surface Area Involvement: Lawrence F. Eichenfield, MD, FAAD
a year ago
by
Maggie L. Shaw(+1 more)

1:00
How Drug Affordability Improves Medication Adherence: Robert Andrews
a year ago
by
Pearl Steinzor(+1 more)

0:56
Why Telehealth Is a Game Changer for Patients With Transportation Issues: Anitha Vijayan, MD
a year ago
by
Sabrina McCrear(+1 more)

0:45
Why Clinical Trials Fail to Reach Many Racial Groups: Gen Li, PhD
a year ago
by
Sabrina McCrear(+1 more)

0:36
Why Digital Control Arms Will Revolutionize Clinical Trials: Gen Li, PhD
a year ago
by
Sabrina McCrear(+1 more)

0:46
Why Breast Cancer Research Dominates Clinical Innovation: Gen Li, PhD
a year ago
by
Sabrina McCrear(+1 more)

0:35
Too Much Access to Bad Information in Menopause Care: Lee Shulman, MD
a year ago
by
Laura Joszt, MA(+1 more)

0:42
Even Providers Are Overwhelmed by Drug Coverage Complexity: Matthew Biszewski, PharmD
a year ago
by
Laura Joszt, MA(+1 more)

1:03
Healthy Habits for Lasting Weight Loss: David Rometo, MD
a year ago
by
David Rometo, MD

1:30
Advancing Health Equity Through Inclusive Care: Sophia Humphreys, PharmD, MHA, BCBBS
a year ago
by
Brooke McCormick(+1 more)

0:43
How Payers Navigate the Economics of Weight Loss Care: David Rometo, MD
a year ago
by
David Rometo, MD

0:39
Supporting Weight Loss With Adjuvant Therapies: David Rometo, MD
a year ago
by
David Rometo, MD

1:38
Advances in Molecular Medicine Challenge Traditional Oncology Payment Models: Sophia Humphreys, PharmD, MHA, BCBBS
a year ago
by
Brooke McCormick(+1 more)

1:26
Telehealth Enables Earlier, Safer Use of Bispecific Antibodies in Cancer Care: Sophia Humphreys, PharmD, MHA, BCBBS
a year ago
by
Brooke McCormick(+1 more)

0:34
Empowering Patients to Overcome Obesity Stigma: David Rometo, MD
a year ago
by
Sabrina McCrear(+1 more)

1:28
Value-Based Care, Infrastructure Drive Access to Disease-Modifying Therapies: Ryan Haumschild, PharmD, MS, MBA, CPEL
a year ago
by
Brooke McCormick(+1 more)

0:52
Preventive Measures in Breast Cancer: Lakshminarayanan Nandagopal, MD
a year ago
by
Lakshminarayanan Nandagopal, MD

0:55
How Multidisciplinary Teams Improve Breast Cancer Decisions: Lakshminarayanan Nandagopal, MD
a year ago
by
Sabrina McCrear(+1 more)

1:21
Local Engagement is the First Step to Driving Change in Health Care: Sucharu "Chris" Prakash, MD
a year ago
by
Brooke McCormick(+1 more)

0:49
Key Factors in Breast Cancer Treatment Decisions: Lakshminarayanan Nandagopal, MD
a year ago
by
Sabrina McCrear(+1 more)

1:16
Equity, Access in Survivorship Care for Women With Breast Cancer: Adriana Olivo, NP
a year ago
by
Sabrina McCrear(+1 more)

1:34
Exploring Provider Notification in Aortic Stenosis Care: Varsha Tanguturi, MD
a year ago
by
Maggie L. Shaw(+1 more)

1:03
Navigating Change in Oncology Care Without Skipping a Beat at PCOC 2025: Davey Daniel, MD
a year ago
by
Brooke McCormick(+1 more)

0:56
The Role of the Breast Cancer Index in Survivorship Care: Adriana Olivo, NP
a year ago
by
Sabrina McCrear(+1 more)

0:51
ACA Dependent Coverage Extension Shows Mixed Impact on Young Adult Substance-Related ED Visits: Refat Rasul Srejon, MPH
a year ago
by
Brooke McCormick(+1 more)

1:29
PCOC 2025 to Tackle Cancer Care Costs, Coverage, and Equity With Practical Strategies: Kathy Oubre, MS
a year ago
by
Brooke McCormick(+1 more)

1:11
Posttreatment Symptoms in Women With Breast Cancer: Adriana Olivo, NP
a year ago
by
Sabrina McCrear(+1 more)
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Asundexian, First FXIa Inhibitor to Prevent Repeat Stroke
2
How Plans, Clinicians Should Handle Gray-Market Retatrutide
3
Pharmacy, Claims Data Show High Resmetirom Persistence in MASH
4
FDA Approves First Dual-Targeted Therapy for Advanced HNSCC
5
